- Tytuł:
- Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial
- Autorzy:
- Źródło:
- In The Lancet 19-25 September 2015 386(9999):1156-1164
Czasopismo naukowe